Skip to content

Construction and application of multimodal integrated diagnosis and treatment model of traditional Chinese and Western medicine for diabetic kidney disease and research on the efficacy mechanism of Qidan Dihuang granules

Construction and application of multimodal integrated diagnosis and treatment model of traditional Chinese and Western medicine for diabetic kidney disease and research on the efficacy mechanism of Qidan Dihuang granules

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001368
Enrollment
Unknown
Registered
2025-07-09
Start date
2024-12-10
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic kidney disease(DKD)

Interventions

Diabetic kidney disease(DKD) group:none
Control group:none
Experimental group:Qidandihuang granules
non-diabetic kidney disease(NDKD) group:no

Sponsors

Southern Medical University hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old and = 75 years old; 2. 2. According to the diagnostic criteria a definite diagnosis of type 2 diabetes mellitus or early diabetic kidney disease; 3. 3. Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Unclear consciousness and inability to accurately express subjective discomfort symptoms; Clearly diagnosed as a psychopath; 2. Clearly diagnosed primary kidney disease or kidney secondary to the immune system blood system drugs etc.; 3. Combined with severe primary diseases such as digestive respiratory cardiovascular hematous and nervous system; 4. Accompanied by more than one malignant tumor; 5. Those with a history of rapidly progressive hypertension and non-cerebrovascular disease in the past 3 months.

Design outcomes

Primary

MeasureTime frame
24-hour urinary microalbumin excretion rate (ALBU);

Secondary

MeasureTime frame
Urinary microalbumin;retinol-binding protein;urinary a1-acid glycoprotein;Kidney color ultrasound;Renal color doppler flow imaging;Emission Computed Tomography;Albumin Creatinine Ratio;urinary albumin excretion rates;urinary transferrin;urinary a1-microglobulin;

Countries

China

Contacts

Public ContactNie Xiaoli

Southern Medical University hospital of Integrated Traditional Chinese and Western Medicine

nxl117@163.com18675867278

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026